Erythropoietin
DrugSubcutaneous injection of erythropoietin 10,000 units
NCT Number: NCT03842254
This study evaluates the effect of erythropoietin on the number and function of regulatory T cells in adults with autoimmune hepatitis. Participants will receive a single dose of erythropoietin, and then the investigators will collect blood at different time points for analysis of regulatory T cell number and function.
Looking for future studies?
Notify Me18 year–74 year
All sexes
Interventional
Early Phase 1
Northwestern Medicine, Chicago, Illinois, United States
There is data from the laboratory that erythropoietin helps stimulate regulatory T cells, a type of immune cell which is thought to combat autoimmunity, but this study will look at whether it does the same thing in adults with autoimmune hepatitis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subcutaneous injection of erythropoietin 10,000 units
Time frame: At time of enrollment, then at 2 weeks, 4 weeks, and 12 weeks.
Calculated relative to baseline collected at time of enrollment
Time frame: At time of enrollment, then at 2 weeks, 4 weeks, and 12 weeks.
Calculated relative to baseline collected at time of enrollment
Time frame: At time of enrollment, then at 2 weeks, 4 weeks, and 12 weeks.
Calculated relative to baseline collected at time of enrollment
Northwestern University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05532345
Autoimmune Diseases, Autoimmune Hepatitis
Beijing, China
View Trial DetailsNCT03217422
Autoimmune Diseases, Autoimmune Hepatitis
Coronado, California, United States
View Trial DetailsNCT05569759
Autoimmune Diseases, Autoimmune Hepatitis
Phoenix, Arizona, United States
View Trial DetailsNCT03743272
Autoimmune Diseases, Autoimmune Hepatitis
Leiden, Netherlands
View Trial Details